BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 230113)

  • 1. Herpes simplex virus: benefit versus risk factors in immunization.
    zur Hausen H
    Dev Biol Stand; 1979; 43():373-9. PubMed ID: 230113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Herpes simplex virus vaccine studies: from past to present].
    Us D
    Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for control of herpes simplex virus disease through immunization.
    Stanberry LR; Cunningham AL; Mindel A; Scott LL; Spruance SL; Aoki FY; Lacey CJ
    Clin Infect Dis; 2000 Mar; 30(3):549-66. PubMed ID: 10722443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seventeen years of application of herpes vaccines in Bulgaria.
    Dundarov S; Andonov P
    Acta Virol; 1994 Aug; 38(4):205-8. PubMed ID: 7879710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex vaccines.
    Hilleman MR
    Cancer Res; 1976 Feb; 36(2 pt 2):857-8. PubMed ID: 56228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Herpes simplex virus, type II: microbiology and clinical experiences with attenuated vaccine].
    Nasemann T; Schaeg G
    Hautarzt; 1973 Apr; 24(4):133-9. PubMed ID: 4351533
    [No Abstract]   [Full Text] [Related]  

  • 7. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
    J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes. Vaccines for HSV.
    Stanberry LR
    Dermatol Clin; 1998 Oct; 16(4):811-6, xiv. PubMed ID: 9891686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Status quo of the researches on HSV vaccines].
    Gao J; Lu JC; Huang YF
    Zhonghua Nan Ke Xue; 2009 Jan; 15(1):60-4. PubMed ID: 19288753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylaxis and treatment of alpha herpesvirus infection--vaccine].
    Kimura H
    Nihon Rinsho; 2000 Apr; 58(4):928-32. PubMed ID: 10774218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Herpes simplex infections].
    Kimmig W
    Z Hautkr; 1989 Apr; 64(4):266-8, 271. PubMed ID: 2544060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of recurrent Herpes simplex].
    Söltz-Szöts J
    Z Haut Geschlechtskr; 1971 Apr; 46(8):267-72. PubMed ID: 4324186
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections.
    Soleimanjahi H; Roostaee MH; Rasaee MJ; Mahboudi F; Kazemnejad A; Bamdad T; Zandi K
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):100-6. PubMed ID: 16420602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine.
    Scriba M
    Med Microbiol Immunol; 1978 Nov; 166(1-4):63-9. PubMed ID: 214688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.
    Weinberg A; Merigan TC
    J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction of latent herpes virus infection in rabbits immunized with subviral herpes simplex virus vaccine.
    Rajcáni J; Kutinová L; Vonka V
    Acta Virol; 1980 May; 24(3):183-93. PubMed ID: 6107035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratin, a dual role in herpes simplex virus pathogenesis.
    Friedman HM
    J Clin Virol; 2006 Jan; 35(1):103-5. PubMed ID: 15916917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus infection: problems and prospects as perceived by a peripatetic pediatrician.
    Nahmias AJ
    Yale J Biol Med; 1980; 53(1):47-54. PubMed ID: 6246686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short-term therapeutic effect of an inactivated herpes simplex virus type 1 vaccine on herpes simplex keratitis].
    Zhang YQ
    Zhonghua Yan Ke Za Zhi; 1983 Nov; 19(6):339-42. PubMed ID: 6327206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.